Skip to main content
Fig. 1 | Advances in Rheumatology

Fig. 1

From: Baricitinib improves pulmonary fibrosis in mice with rheumatoid arthritis-associated interstitial lung disease by inhibiting the Jak2/Stat3 signaling pathway

Fig. 1

Changes in the general condition of the mice. Control: control group; CIA: model group; CIA + baricitinib: intervention group. a Changes in body weight of mice in each group: *control group vs. model group, # control group vs. intervention group; *P < 0.05, **P < 0.01, #P < 0.05, ##P < 0.01. b Changes in joint scores of the mice in each group. c Mouse joint pathology in each group: Representative images of the paws of mice in the control, model and intervention groups. The paws of mice in the model group were obviously red, swollen and stiff

Back to article page

Advances in Rheumatology

ISSN: 2523-3106